Seres Therapeutics, Inc. (MCRB)

Last Three Months

26-Aug-24 -- 25-Nov-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Strong Sell

Insider Trading Sentiment: Strong Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

21

0

1

+1

0

+2

0

+3

Two Year Chart

26-Nov-22 -- 25-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
19-Nov-24 4:15 PM View:	18-Nov-24 Planned Option Sale ($0.50K)	Henn Matthew R. See Remarks		Seres Therapeutics, Inc. - MCRB	2% 75.89K to 77.77K	0	0	--	--	Show Txns Hide Txns

19-Nov-24 4:20 PM View:	18-Nov-24 Planned Option Sale ($0.53K)	von Moltke Lisa See Remarks		Seres Therapeutics, Inc. - MCRB	7% 30.42K to 32.41K	0	0	--	--	Show Txns Hide Txns

19-Nov-24 4:15 PM View:	18-Nov-24 Planned Option Sale ($0.40K)	Young Teresa L. See Remarks		Seres Therapeutics, Inc. - MCRB	2% 88.48K to 90.4K	0	0	--	--	Show Txns Hide Txns

19-Nov-24 4:15 PM View:	18-Nov-24 Planned Option Sale ($1.35K)	Shaff Eric D. CEO and President Director		Seres Therapeutics, Inc. - MCRB	3% 165.08K to 170.39K	0	0	--	--	Show Txns Hide Txns